Skip to content

Archives

  • September 2026
  • June 2026
  • October 2025
  • August 2025
  • January 2025
  • September 2024
  • November 2023
  • October 2023
  • April 2023
  • October 2022
  • September 2021
  • May 2021
  • April 2021

Categories

  • Uncategorized
SOLA BIOSCIENCES
SOLA Biosciences Logo
Select Language |
English 🇺🇸 | 日本語 🇯🇵
  • Home
  • About
  • Science
  • Pipeline
  • News & Media
  • Contact
November 1, 2023

Post navigation

  • Previews
    SOLA Biosciences Shares Preclinical Proof-of-Concept Data for SOL-257, a Gene Therapy Targeting Misfolded TDP-43 in ALS at 22nd Annual NEALS Meeting.
  • Next
    SOLA Biosciences Presents Preclinical Proof-of-Concept Data for SOL-257, a Gene Therapy Targeting Misfolded TDP-43 in ALS, at Neuroscience 2023 and ALS One Symposium.
SOLA Biosciences Logo
About
  • Pipeline
  • Science
  • News & Media
  • Contact
  • Privacy Policy
  • Terms and Conditions
Useful Links
  • Home
  • About
  • Careers
Information

Info@sola-bio.com

27 Strathmore Road
Natick, MA 01760

© 2026 All Rights Reserved.